Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
A. Ardelean & R. Redolat. (2023) Supporting Behavioral and Psychological Challenges in Alzheimer Using Technology: A Systematic Review. Activities, Adaptation & Aging 0:0, pages 1-32.
Read now
Read now
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Adrie A. J. Gerritsen, Christian Bakker, Esther Bruls, Frans R. J. Verhey, Yolande A. L. Pijnenburg, Joany K. Millenaar, Marjolein E. de Vugt & Raymond T. C. M. Koopmans. (2021) Psychotropic drug use in community-dwelling people with young-onset dementia: two-year course and determinants. Aging & Mental Health 25:1, pages 179-186.
Read now
Read now
Chieh-Hsin Lin, Hui-Ting Yang, Ping-Kun Chen, Shi-Heng Wang & Hsien-Yuan Lane. (2020) Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD). Neuropsychiatric Disease and Treatment 16, pages 509-518.
Read now
Read now
Jeroen S. Kok, Richard C. Oude Voshaar & Erik J. A. Scherder. (2020) Psychotropic drug use in residents with dementia living in small-scaled special care facilities; a longitudinal study. Aging & Mental Health 24:4, pages 689-696.
Read now
Read now
Articles from other publishers (58)
Peihao Fan, Lang Zeng, Ying Ding, Julia Kofler, Jonathan Silverstein, Joshua Krivinko, Robert A. Sweet & Lirong Wang. (2023) Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease. CPT: Pharmacometrics & Systems Pharmacology 12:8, pages 1119-1131.
Crossref
Crossref
Antonio L. Teixeira, Laís Bhering Martins, Thiago Macedo e Cordeiro, Lijin Jose, Robert Suchting, Holly M. Holmes, Ron Acierno & Hyochol Ahn. (2023) Home-based tDCS for apathy in Alzheimer’s disease: a protocol for a randomized double-blinded controlled pilot study. Pilot and Feasibility Studies 9:1.
Crossref
Crossref
Hamid Ullah, Abrar Hussain, Muhammad Asif, Faheem Nawaz & Mahmood Rasool. (2023) Natural Products as Bioactive Agents in the Prevention of Dementia. CNS & Neurological Disorders - Drug Targets 22:4, pages 466-476.
Crossref
Crossref
Janet C. Hovde, Carol C. Geisler, Janet M. Marinelli & Briley Hale. (2023) Holistic Interventions to Address Pain, Anxiety, and Distressing Behaviours in Long-Term Care Residents. Journal of Long Term Care, pages 12-22.
Crossref
Crossref
Ximing Shen, Yun Suen Pai, Dai Kiuchi, Kehan Bao, Tomomi Aoki, Hikari Meguro, Kanoko Oishi, Ziyue Wang, Sohei Wakisaka & Kouta Minamizawa. (2023) Dementia Eyes: Co-Design and Evaluation of a Dementia Education Augmented Reality Experience for Medical Workers. Dementia Eyes: Co-Design and Evaluation of a Dementia Education Augmented Reality Experience for Medical Workers.
Denise Wilfling, Kristina Flägel, Jost Steinhäuser & Katrin Balzer. (2023) Specifics of and training needs in the inter-professional home care ofpeople with dementia. Pflege 36:2, pages 67-76.
Crossref
Crossref
Michael Makhinson, Juliana Gomez-Makhinson, Catherine Jennings & Sergio Huerta. (2023) Ethics consultation in patients with behavioral and psychological symptoms of dementia. Clinical Ethics, pages 147775092311600.
Crossref
Crossref
Yanxia Chen, Kung Wang, Tao Huang, Chun Xie & Zuosong Chen. (2023) Exercise interventions ameliorate neuropsychiatric symptoms in dementia: A meta-analysis. Mental Health and Physical Activity 24, pages 100496.
Crossref
Crossref
Chan-Young Kwon & Boram Lee. (2023) Complementary and integrative medicines for behavioral and psychological symptoms of dementia: Overview of systematic reviews. EXPLORE 19:2, pages 176-194.
Crossref
Crossref
Maria Gustafsson, Muna Altufaili & Maria Sjölander. (2022) Prevalence of Drugs and Drug Combinations that Increase Risk of Prolonged QT Time Among People with Major Neurocognitive Disorder Living in Sweden: A Cross-Sectional Registry Study. Drugs - Real World Outcomes 10:1, pages 61-68.
Crossref
Crossref
Pasqualina Stranieri & Rosa Maria Cordaro. (2023) Benzodiazepines in the Treatment of Behavioural and Psychological Symptoms Associated with Dementia and Their Impact on Cognitive Impairment: Review of Clinical Evidence. European Medical Journal.
Crossref
Crossref
CTSudhir Kumar, Mathew Varghese, Venugopal Duddu, Sridhar Vaitheswaran, Shrikant Srivastava, KS Shaji, Sanju George, NarendraKumar Singh, Nishant Goyal, Ajay Bakhla, S Shaji, Vikas Menon, Tajamul Hussain, Sandeep Grover, Aseem Mehra, LokeshKumar Singh, A Purushotham, Avinash Desousa, Nilesh Shah, Sagar Karia, I Anand, Shafana Afroon, Ritambhara Mehta, Gargi Kukreja, Dimple Dadarwala, KL Vidya, PT Sivakumar, Preeti Sinha, Shivashankar Reddy, Thomas Isaac & Mina Chandra. (2023) Indian Psychiatric Society multicentre study: Diagnostic patterns, comorbidity and prescription practices for patients with Dementia. Indian Journal of Psychiatry 65:1, pages 52.
Crossref
Crossref
Nobutaka Ayani, Nozomu Oya, Riki Kitaoka, Akiko Kuwahara, Takeshi Morimoto, Mio Sakuma & Jin Narumoto. (2022) Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study. BMJ Quality & Safety 31:12, pages 878-887.
Crossref
Crossref
Alok Joshi, Stephen Todd, David P. Finn, Paula L. McClean & KongFatt Wong-Lin. (2022) Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals. BMC Medical Informatics and Decision Making 22:1.
Crossref
Crossref
Winnie Sun, Rabia Akhter, Alvaro Uribe-Quevedo, Daniel Presas, Ramiro Liscano & Sheri Horsburgh. (2022) A Web and Nonimmersive VR Approach for Reminiscence Therapy: A Caregiver Perspective Comparison. A Web and Nonimmersive VR Approach for Reminiscence Therapy: A Caregiver Perspective Comparison.
Thilanka Jagoda, Sarath Rathnayake & Samath Dharmaratne. (2022) Information needs and mHealth applications for carers of people with dementia in managing behavioural and psychological symptoms of care recipients: an integrative review protocol. BMJ Open 12:6, pages e060414.
Crossref
Crossref
Yingyang Zhang, Hao Luo, Gloria H.Y. Wong, Mei Zhao, Xiaozhen Lv, Terry Y.S. Lum, Celine S.L. Chui, Xin Yu, Ian C.K. Wong & Huali Wang. (2022) Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China. Journal of the American Medical Directors Association 23:6, pages 1073-1079.e3.
Crossref
Crossref
Anna Song Beeber, Sheryl Zimmerman, Christopher J. Wretman, Stephanie Palmertree, Kush Patel & Philip D. Sloane. (2021) Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. Journal of Applied Gerontology 41:3, pages 798-805.
Crossref
Crossref
Jonas Kindstedt, Maria Sjölander, Hugo Lövheim & Maria Gustafsson. (2021) Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries. European Journal of Clinical Pharmacology 78:3, pages 477-487.
Crossref
Crossref
P. V. Indu. 2022. Handbook of Aging, Health and Public Policy. Handbook of Aging, Health and Public Policy
1
18
.
Yu-Jung Jenny Wei, Siegfried Schmidt, Cheng Chen, Roger B. Fillingim, M. Carrington Reid, Steven DeKosky, Laurence Solberg, Marco Pahor, Babette Brumback & Almut G. Winterstein. (2021) Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia. Alzheimer's Research & Therapy 13:1.
Crossref
Crossref
Johannes Teselink, Kritleen K. Bawa, Grace KY Koo, Krushnaa Sankhe, Celina S. Liu, Mark Rapoport, Paul Oh, Susan Marzolini, Damien Gallagher, Walter Swardfager, Nathan Herrmann & Krista L. Lanctôt. (2021) Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review. Ageing Research Reviews 72, pages 101499.
Crossref
Crossref
Ting Zhou, Jiling Qu, Huiping Sun, Mengxin Xue, Yijing Shen & Yongbing Liu. (2021) Research Trends and Hotspots on Montessori Intervention in Patients With Dementia From 2000 to 2021: A Bibliometric Analysis. Frontiers in Psychiatry 12.
Crossref
Crossref
Grace Hsin-Min Wang, Kenneth K C Man, Wei-Hung Chang, Tzu-Chi Liao & Edward Chia-Cheng Lai. (2021) Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series. BMJ, pages n1925.
Crossref
Crossref
Güler Duru Aşiret, Cemile Kütmeç Yılmaz & Kadriye Sayın Kasar. (2021)
Investigation of the effects of interventions made according to the
P
rogressively
L
owered
S
tress
T
hreshold
M
odel on the care outcomes of
A
lzheimer patients and their families: a randomized clinical trial
. Psychogeriatrics 21:5, pages 738-748.
Crossref
Crossref
Paula Piirainen, Hanna‐Mari Pesonen, Helvi Kyngäs & Satu Elo. (2021) Challenging situations and competence of nursing staff in nursing homes for older people with dementia. International Journal of Older People Nursing 16:5.
Crossref
Crossref
Alexandra Martini Oliveira, Marcia Radanovic, Patricia Cotting Homem de Mello, Patricia Cardoso Buchain, Adriana Dias Barbosa Vizzotto, Janaína Harder, Florindo Stella, Laura N. Gitlin, Catherine Verrier Piersol, Leandro L.C. Valiengo & Orestes Vicente Forlenza. (2021) Adjunctive Therapy to Manage Neuropsychiatric Symptoms in Moderate and Severe Dementia: Randomized Clinical Trial Using an Outpatient Version of Tailored Activity Program. Journal of Alzheimer's Disease 83:1, pages 475-486.
Crossref
Crossref
Jenny Nguyen, Ina Ko, Santiago Martinez-Sosa & Ruth Mizoguchi. (2021) Ward based management of behavioural and psychological symptoms of dementia. BMJ, pages n1779.
Crossref
Crossref
Chan-Young Kwon & Boram Lee. (2021) Herbal Medicine for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Chan-Young Kwon & Boram Lee. (2021) Acupuncture for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 10:14, pages 3087.
Crossref
Crossref
Claudia Carrarini, Mirella Russo, Fedele Dono, Filomena Barbone, Marianna G. Rispoli, Laura Ferri, Martina Di Pietro, Anna Digiovanni, Paola Ajdinaj, Rino Speranza, Alberto Granzotto, Valerio Frazzini, Astrid Thomas, Andrea Pilotto, Alessandro Padovani, Marco Onofrj, Stefano L. Sensi & Laura Bonanni. (2021) Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions. Frontiers in Neurology 12.
Crossref
Crossref
Valeria Calsolaro, Grazia Daniela Femminella, Sara Rogani, Salvatore Esposito, Riccardo Franchi, Chukwuma Okoye, Giuseppe Rengo & Fabio Monzani. (2021) Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics. Pharmaceuticals 14:3, pages 246.
Crossref
Crossref
Karlijn J. Joling, Maud ten Koppel, Hein P.J. van Hout, Bregje D. Onwuteaka‐Philipsen, Anneke L. Francke, Robert A. Verheij, Jos W.R. Twisk & Rob J. van Marum. (2020) Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards. International Journal of Geriatric Psychiatry 36:3, pages 443-451.
Crossref
Crossref
Shakti Shrestha, Arjun Poudel, Magnolia Cardona, Kathryn J. Steadman & Lisa M. Nissen. (2021) Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis. Therapeutic Advances in Drug Safety 12, pages 204209862110523.
Crossref
Crossref
Zanna J. Voysey, Roger A. Barker & Alpar S. Lazar. (2020) The Treatment of Sleep Dysfunction in Neurodegenerative Disorders. Neurotherapeutics 18:1, pages 202-216.
Crossref
Crossref
Albert Lukas, Wilco P. Achterberg & Bettina S. Husebo. 2020. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
1
16
.
Albert Lukas, Wilco P. Achterberg & Bettina S. Husebo. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
3685
3700
.
Eosu Kim, Matthew A. White, Benjamin U. Phillips, Laura Lopez-Cruz, Hyunjeong Kim, Christopher J. Heath, Jong Eun Lee, Lisa M. Saksida, Jemeen Sreedharan & Timothy J. Bussey. (2020) Coexistence of perseveration and apathy in the TDP-43Q331K knock-in mouse model of ALS–FTD. Translational Psychiatry 10:1.
Crossref
Crossref
Tatiana-Danai Dimitriou, Eleni Verykouki, John Papatriantafyllou, Anastasia Konsta, Dimitrios Kazis & Magda Tsolaki. (2020) Non-Pharmacological interventions for the anxiety in patients with dementia. A cross-over randomised controlled trial. Behavioural Brain Research 390, pages 112617.
Crossref
Crossref
Tobias Möllers, Laura Perna, Hannah Stocker, Peter Ihle, Ingrid Schubert, Ben Schöttker, Lutz Frölich & Hermann Brenner. (2020) New use of psychotropic medication after hospitalization among people with dementia. International Journal of Geriatric Psychiatry 35:6, pages 640-649.
Crossref
Crossref
Blair Rajamaki, Sirpa Hartikainen & Anna-Maija Tolppanen. (2020) Psychotropic Drug-Associated Pneumonia in Older Adults. Drugs & Aging 37:4, pages 241-261.
Crossref
Crossref
Martin Vališ, Jiří Masopust & Zbyšek Pavelek. (2020) Pharmacotherapy of non-Alzheimer's types of dementia. Neurologie pro praxi 21:1, pages 41-45.
Crossref
Crossref
Yia-Ping Liu, Wu-Chien Chien, Chi-Hsiang Chung, Hsin-An Chang, Yu-Chen Kao & Nian-Sheng Tzeng. (2020) Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan. Frontiers in Pharmacology 11.
Crossref
Crossref
Minmin Leng, Yajie Zhao & Zhiwen Wang. (2020) Comparative efficacy of non-pharmacological interventions on agitation in people with dementia: A systematic review and Bayesian network meta-analysis. International Journal of Nursing Studies 102, pages 103489.
Crossref
Crossref
Filippo Caraci, Mario Santagati, Giuseppe Caruso, Dario Cannavò, Gian Marco Leggio, Salvatore Salomone & Filippo Drago. (2020) New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin. F1000Research 9, pages 686.
Crossref
Crossref
Sagrario Manzano-Palomo, Luis F. Agüera-Ortiz, Alexandre García-Caballero, José Martínez-Raga, Tomás Ojea-Ortega, Raquel Sánchez-Valle, Manuel Antón-Jiménez, José A. Monge-Argilés & Isabel Ramos-García. (2020) Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus. Dementia and Geriatric Cognitive Disorders 49:6, pages 573-582.
Crossref
Crossref
Albert Lukas, Wilco P. Achterberg & Bettina S. Husebo. 2020. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
1
16
.
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye & Fabio Monzani. (2019) The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Marie Turmo Lornstad, Marte Aarøen, Sverre Bergh, Jūratė Šaltytė Benth & Anne-Sofie Helvik. (2019) Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline. BMC Geriatrics 19:1.
Crossref
Crossref
Boru Jin & Huayan Liu. (2019) Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis. Journal of Neurology 266:10, pages 2363-2375.
Crossref
Crossref
P. Karcher. (2019) Les cris : prendre soin en situation de complexité et d’incertitude. NPG Neurologie - Psychiatrie - Gériatrie 19:112, pages 209-214.
Crossref
Crossref
Felix Margenfeld, Carina Klocke & Stefanie Joos. (2019) Manual massage for persons living with dementia: A systematic review and meta-analysis. International Journal of Nursing Studies 96, pages 132-142.
Crossref
Crossref
Mehnaz Ahmed, Marlene Malik, Johannes Teselink, Krista L. Lanctôt & Nathan Herrmann. (2019) Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia. Drugs & Aging 36:7, pages 589-605.
Crossref
Crossref
Melanie Bienas, Irmela Gnass, Benjamin Mayer, Lukas Radbruch & Albert Lukas. (2019) Herausfordernde Verhaltensweisen und Schmerz bei DemenzChallenging behavior and pain in dementia. Der Schmerz 33:3, pages 212-219.
Crossref
Crossref
Heidi Taipale, Pasi Lampela, Marjaana Koponen, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen & Anna-Maija Tolppanen. (2019) Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer’s Disease-Matched Cohort Study. Journal of Alzheimer's Disease 68:1, pages 127-136.
Crossref
Crossref
Jingzhu Hao. (2019) Risk Factors and Clinical Treatments of Alzheimer’s Disease. Journal of Physics: Conference Series 1168, pages 032120.
Crossref
Crossref
E. G. Mendelevich. (2018) Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders. Neurology, Neuropsychiatry, Psychosomatics 10:3, pages 129-134.
Crossref
Crossref
Sue Jordan, Patricia Logan, Gerwyn Panes, Mojtaba Vaismoradi & David Hughes. (2018) Adverse Drug Reactions, Power, Harm Reduction, Regulation and the ADRe Profiles. Pharmacy 6:3, pages 102.
Crossref
Crossref